Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population

Trial Profile

Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population

Discontinued
Phase of Trial: Phase I

Latest Information Update: 14 Feb 2017

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Nephrotic syndrome; Renal failure
  • Focus Biomarker; Pharmacodynamics; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 Feb 2017 Status changed from recruiting to discontinued.
    • 06 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top